CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,826,000 | +134.2% | 267,627 | +12.3% | 0.00% | +200.0% |
| Q2 2022 | $5,903,000 | -17.9% | 238,226 | -17.0% | 0.00% | 0.0% |
| Q1 2022 | $7,192,000 | -33.2% | 286,896 | -3.0% | 0.00% | -50.0% |
| Q4 2021 | $10,770,000 | +112.8% | 295,798 | -0.1% | 0.00% | +100.0% |
| Q3 2021 | $5,062,000 | +34.1% | 296,037 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $3,774,000 | -65.2% | 281,892 | +33.3% | 0.00% | -50.0% |
| Q1 2021 | $10,837,000 | -19.9% | 211,487 | -3.2% | 0.00% | -33.3% |
| Q4 2020 | $13,528,000 | +11.0% | 218,468 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $12,191,000 | +0.0% | 222,454 | +5.0% | 0.00% | 0.0% |
| Q2 2020 | $12,185,000 | +50.8% | 211,771 | +5.3% | 0.00% | 0.0% |
| Q1 2020 | $8,079,000 | -1.6% | 201,093 | -3.1% | 0.00% | +50.0% |
| Q4 2019 | $8,207,000 | +575.5% | 207,525 | +15.8% | 0.00% | – |
| Q3 2019 | $1,215,000 | -25.3% | 179,136 | +2.4% | 0.00% | – |
| Q2 2019 | $1,627,000 | -12.3% | 174,910 | +30.9% | 0.00% | -100.0% |
| Q1 2019 | $1,856,000 | +21.7% | 133,619 | -4.4% | 0.00% | – |
| Q4 2018 | $1,525,000 | -4.9% | 139,805 | +10.2% | 0.00% | – |
| Q3 2018 | $1,604,000 | +2.5% | 126,848 | +6.8% | 0.00% | – |
| Q2 2018 | $1,565,000 | +7.9% | 118,778 | +11.4% | 0.00% | – |
| Q1 2018 | $1,450,000 | +119.7% | 106,620 | -3.8% | 0.00% | – |
| Q4 2017 | $660,000 | -19.6% | 110,886 | +0.3% | 0.00% | – |
| Q3 2017 | $821,000 | -17.7% | 110,562 | +3.7% | 0.00% | – |
| Q2 2017 | $998,000 | +27.3% | 106,615 | -0.9% | 0.00% | – |
| Q1 2017 | $784,000 | -2.7% | 107,625 | -1.3% | 0.00% | – |
| Q4 2016 | $806,000 | +27.3% | 108,998 | +3.9% | 0.00% | – |
| Q3 2016 | $633,000 | +20.3% | 104,898 | -10.5% | 0.00% | – |
| Q2 2016 | $526,000 | +122.9% | 117,265 | +23.5% | 0.00% | – |
| Q1 2016 | $236,000 | -63.6% | 94,951 | +18.6% | 0.00% | – |
| Q4 2015 | $648,000 | +24.9% | 80,056 | -6.5% | 0.00% | – |
| Q3 2015 | $519,000 | -44.9% | 85,660 | -25.1% | 0.00% | – |
| Q2 2015 | $942,000 | +13.5% | 114,418 | +4.0% | 0.00% | – |
| Q1 2015 | $830,000 | +10.5% | 109,999 | 0.0% | 0.00% | – |
| Q4 2014 | $751,000 | +50.2% | 109,999 | -1.0% | 0.00% | – |
| Q3 2014 | $500,000 | -61.5% | 111,163 | -50.0% | 0.00% | – |
| Q2 2014 | $1,300,000 | +75.9% | 222,326 | +99.7% | 0.00% | – |
| Q1 2014 | $739,000 | +26.3% | 111,354 | +10.1% | 0.00% | – |
| Q4 2013 | $585,000 | -46.1% | 101,134 | -48.2% | 0.00% | – |
| Q3 2013 | $1,086,000 | -18.9% | 195,172 | +106.1% | 0.00% | – |
| Q2 2013 | $1,339,000 | – | 94,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |